# US 2023/0389929 A1 · Method for treating scalp arteriovenous fistula using micro vascular plug

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0389929 A1
- Document ID: US20230389929A1
- Status: Published application
- Kind: A1
- Application number: 18/328,356
- Filed: 2023-06-02
- Published: 2023-12-07
- Earliest claimed: 2022-06-02
- Assignees: Jordan University of Science and Technology
- Applicants: Jordan University of Science and Technology
- Inventors: Khaled ALWANEH; Liqaa Raffee; Moh'd Al-Barbarawi; Hassan Alawneh
- Web page: https://patentgrep.com/patent/US20230389929A1

## CPC

- A61B 17/12109: {in a blood vessel}
- A61B 17/12113: {within an aneurysm}
- A61B 17/0057: {Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect (sutures A61B17/04; closing rectum or urethra near body surface A61F2/0009)}
- A61B 17/12159: {Solid plugs; being solid before insertion}
- A61B 17/12172: {having a pre-set deployed three-dimensional shape (methods of manufacturing A61B2017/00526)}
- A61B 17/12177: {comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated}
- A61B 2017/00575: {for closure at remote site, e.g. closing atrial septum defects}
- A61B 2017/00592: {Elastic or resilient implements}
- A61B 2017/00597: {Implements comprising a membrane}
- A61B 2017/00601: {Implements entirely comprised between the two sides of the opening}
- A61B 2017/00623: {Introducing or retrieving devices therefor}
- A61B 2017/00641: {for closing fistulae, e.g. anorectal fistulae}
- A61B 2017/00778: {Operations on blood vessels (A61B2017/22097, A61B2017/320741 take precedence)}
- A61B 2017/1205: {Introduction devices}
- A61B 2090/3966: {Radiopaque markers visible in an X-ray image}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method of treating scalp arteriovenous fistula may include introducing a micro-vascular plug into an affected blood vessel, positioning the micro-vascular plug at a site of a fistula, and securing the micro-vascular plug to occlude blood flow through the fistula. Such a method may also include conducting contrast-enhanced Magnetic Resonance Imaging of a brain to evaluate a scalp mass.

## Claims

### Claim 1

A method of treating scalp arteriovenous fistula (“AVF”) comprising introducing a micro-vascular plug (“MVP”) into an affected blood vessel, positioning the MVP at a site of a fistula, and securing the MVP to occlude blood flow through the fistula.

### Claim 2 (depends on 1)

The method of claim 1, further comprising conducting contrast-enhanced Magnetic Resonance Imaging (“MRI”) of a brain to evaluate a scalp mass.

### Claim 3 (depends on 1)

The method of claim 1, further comprising inserting a sheath into a targeted femoral artery directed into a temporal artery.

### Claim 4 (depends on 1, 3)

The method of claim 3, wherein the sheath is a 6F short pediatric sheath. The method of claim 1, further comprising introducing a micro-catheter with a micro-wire inside a guiding catheter to reach pseudoaneurysm.

### Claim 6 (depends on 5)

The method of claim 5, wherein the micro-catheter is Rebar-27 reinforced micro-catheter.

### Claim 7 (depends on 1)

The method of claim 1, further comprising implanting one or more MVPs.

### Claim 8 (depends on 1)

The method of claim 1, further comprising placing at least one coil behind the MVP to prevent their migration.

### Claim 9 (depends on 1)

The method of claim 1, further comprising tracking through a tortuous course of the micro-catheter facilitated by a highly flexible delivery wire and device.

### Claim 10 (depends on 1)

The method of claim 1, further comprising holding the highly flexible delivery wire and device in place by oversizing the device to the target vessel diameter, and a partial polytetrafluoroethylene cover to enable rapid occlusion.

### Claim 11 (depends on 1)

The method of claim 1, further comprising immersing the MVP device in a bowl containing heparinized saline and withdrawn into a loader catheter by pulling back a flexible delivery wire until a distal tip of the MVP is fully sheathed.

### Claim 12 (depends on 1)

The method of claim 1, further comprising inserting a sheath distal end into a micro-catheter hub positioned in the affected blood vessel through a connector.

### Claim 13 (depends on 12)

The method of claim 12, wherein the connector is a Y-connector.

### Claim 14 (depends on 1)

The method of claim 1, further comprising tightening a hemostasis valve.

### Claim 15 (depends on 1)

The method of claim 1, further comprising advancing a pusher wire through a micro-catheter until a distal platinum marker of the MVP is aligned with a distal marker of the micro-catheter.

### Claim 16 (depends on 1)

The method of claim 1, further comprising unsheathing the MVP by slowly withdrawing a micro-catheter and rotating a nitinol pusher wire in a counter-clockwise direction.
